Kim Hye Jeong, Lee Ji In, Cho Yoon Young, Lee Soo Youn, Kim Jung Han, Jung Byong Chang, Kim Sun Wook, Chung Jae Hoon, Min Yong-Ki, Lee Myung-Shik, Lee Moon-Kyu, Kim Jae Hyeon
Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
Endocr J. 2015;62(3):243-50. doi: 10.1507/endocrj.EJ14-0384. Epub 2014 Dec 4.
The aim of this study was to determine the diagnostic efficacy of free metanephrines in plasma samples drawn in the seated position compared with 24-h urinary metanephrines in detecting pheochromocytomas in Asian patients. This prospective study was conducted at Samsung Medical Center between May 2010 and July 2011. The study contained 245 subjects, including 28 patients with histologically-proven pheochromocytoma, 44 with histologically-proven non-pheochromocytoma, 112 controls suspected of having tumors but with negative investigations during two or more years of follow-up, and 45 healthy normotensive volunteers. Plasma-free metanephrines were measured by LC-MS/MS. The cut-off values with optimal sensitivity and specificity for plasma metanephrine and plasma normetanephrine were 0.33 nmol/L and 0.61 nmol/L, respectively. Both the plasma metanephrines measurement and urinary metanephrines measurement had a sensitivity of 96.4% (p = 1.00). However, the urinary metanephrines measurement was significantly more specific than the plasma metanephrines measurement (94.2% vs. 75.6%; p < 0.001). When we applied cut-off values based on BMI, specificity improved from 75.6% to 87.2%, with a comparable gain in sensitivity. From a diagnostic perspective, measurement of free metanephrines in plasma drawn in the seated position is highly sensitive but insufficiently specific when compared with measurement of 24-h urinary fractionated metanephrines. The specificity may be improved by applying cut-off values based on BMI. We suggest that free metanephrines in plasma drawn from seated position can also be used as an initial screening test to ensure that pheochromocytomas are not missed in Asian patients.
本研究的目的是确定与24小时尿间甲肾上腺素相比,坐位采集的血浆样本中游离间甲肾上腺素在检测亚洲患者嗜铬细胞瘤时的诊断效能。这项前瞻性研究于2010年5月至2011年7月在三星医疗中心进行。该研究包含245名受试者,其中包括28例经组织学证实的嗜铬细胞瘤患者、44例经组织学证实的非嗜铬细胞瘤患者、112名怀疑患有肿瘤但在两年多的随访期间检查结果为阴性的对照者以及45名健康的血压正常志愿者。采用液相色谱-串联质谱法测定血浆游离间甲肾上腺素。血浆间甲肾上腺素和血浆去甲间甲肾上腺素具有最佳敏感性和特异性的临界值分别为0.33 nmol/L和0.61 nmol/L。血浆间甲肾上腺素测定和尿间甲肾上腺素测定的敏感性均为96.4%(p = 1.00)。然而,尿间甲肾上腺素测定的特异性显著高于血浆间甲肾上腺素测定(94.2%对75.6%;p < 0.001)。当我们应用基于体重指数的临界值时,特异性从75.6%提高到87.2%,敏感性也有类似提高。从诊断角度来看,与24小时尿分馏间甲肾上腺素测定相比,坐位采集的血浆中游离间甲肾上腺素测定具有高度敏感性,但特异性不足。通过应用基于体重指数的临界值可以提高特异性。我们建议,坐位采集的血浆中游离间甲肾上腺素也可作为初步筛查试验,以确保不会漏诊亚洲患者的嗜铬细胞瘤。